Why Lifestyle Medicine?
The question ‘Why Lifestyle Medicine?’ is answered by discussing the concept of chronic diseases and their increased prevalence rates that are resistant to current care models. The great burden of this problem is described and the need for a new chronic disease care model is proposed. Epidemiological dimensions as well as issues with health messaging and campaigns that are scalable to address this problem are presented. A new lifestyle medicine paradigm that incorporates the facets of preventive medicine, wellness, and health promotion, and disease complexity and residual risk is proposed and involves novel tools and metrics, such as the disability-adjusted life year (DALY) and the quality-adjusted life year (QALY). In short, the need for lifestyle medicine is based on persistent drivers of chronic disease and inadequacy of current care models to address complexity, residual risk, and challenging health-care socioeconomics.
KeywordsLifestyle medicine Chronic disease Disease complexity Preventive medicine Health promotion
Centers for Disease Control and Prevention
Disability-adjusted life year
Global burden of disease
Morbidity and Mortality Weekly Report
Quality-adjusted life year
- 1.Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014. doi:10.1161/01.cir.0000441139.02102.80. Accessed 22 June 2014.Google Scholar
- 2.CDC. Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors—United States, 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1248–51.Google Scholar
- 3.Centers for Disease Control and Prevention. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2010–2012. MMWR Morb Mortal Wkly Rep. 2013;62:869–92.Google Scholar
- 5.Alzheimer’s Association. Alzheimer’s facts and figures. 2015. http://www.alz.org/alzheimers_disease_facts_and_figures.asp#prevalence/alzheimers_disease_facts_and_figures.asp#prevalence. Accessed 22 June 2014.
- 6.Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Mineral Res. 2014. doi:10.1002/jbmr.2269.Google Scholar
- 7.CDC. National Diabetes Statistics Report. 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed 22 June 2014.
- 8.CDC. Current depression among adults—United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep. 2010;59:1229–35.Google Scholar
- 9.American Lung Association, Epidemiology and Statistics Unit. Estimated prevalence and incidence of lung disease. 2014 http://www.lung.org/finding-cures/our-research/trend-reports/estimated-prevalence.pdf/finding-cures/our-research/trend-reports/estimated-prevalence.pdf. Accessed 22 June 2014.
- 11.CDC. Diagnoses of HIV infection in the United States and Dependent Areas. 2011. http://www.cdc.gov/hiv/library/reports/surveillance/2011/surveillance_Report_vol_23.html#3/hiv/library/reports/surveillance/2011/surveillance_Report_vol_23.html#3. Accessed 22 June 2014.
- 14.CDC. Chronic disease and health promotion. 2015. http://cdc.gov/chronicdisease/overview/index.htm. Accessed 18 July 2014.
- 15.CDC. Healthy people 2020. 2011. http://www.cdc.gov/nchs/healthy_people/hp2020.htm. Accessed 22 June 2014.
- 16.CDC. CDC grand rounds: childhood obesity in the United States. MMWR Morb Mortal Wkly Rep. 2011;60:42–6.Google Scholar
- 18.CDC. Awareness of prediabetes—United States, 2005–2010. MMWR. 2013;62:209–12.Google Scholar
- 23.CDC. Obesity—United States, 1999–2010. MMWR Surveill Summ. 2013;62:120–8.Google Scholar
- 25.Tarleton HP, Ryan-Ibarra S, Induni M. Chronic disease burden among cancer survivors in the California behavorial risk factor surveillance system, 2009–2010. J Cancer Surviv. 2014. doi:10.1007/s11764-014-0350-x.Google Scholar
- 33.Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and profected to 2020. Cambridge: Harvard University Press; 1996.Google Scholar
- 35.World Health Organization. The global burden of disease: 2004 update. 2015. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed 12 July 2014.
- 44.Parekh AK, Kronick R, Tavenner M. Optimizing health for persons with multiple chronic conditions. JAMA. 2014. doi:10.1001/jama.2014.10181.Google Scholar
- 47.World Health Organization. The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index2.html. Accessed 18 July 2014.
- 48.President of the General Assembly, United Nations. Draft political declaration of the high-level meeting on the prevention and control of non-communicable diseases. http://www.un.org/en/ga/ncdmeeting2011/pdf/NCD_draft_political_declaration.pdf. Accessed 15 July 2014.
- 49.World Health Organization. Non-communicable diseases and mental health. http://www.who.int/nmh/publications/9789241597418en/nmh/publications/9789241597418en/. Accessed 15 July 2014.
- 51.American Association of Clinical Endocrinologists. 2014 AACE/ACE Consensus Conference of Obesity. http://mms.businesswire.com/media/20140325006164/en/408761/1/aace.pdf [see EC.5. in document]. Accessed 18 July 2014.
- 52.Harmon P. A glossary of commonly used business process terms. http://www.ispi.org/archives/Glossary/PHarmon.pdf. Accessed 7 Sept 2014.
- 53.Sturmberg JP. Multimorbidity and chronic disease: an emergent perspective. J Eval Clin Pract. 2014. doi:10.1111/jep.12126.Google Scholar
- 54.McGrath JW, Winchester MS, Kaawa-Mafigiri D, et al. Challenging the paradigm: anthropological perspectives on HIV as a chronic disease. Med Anthropol. 2014. doi:10.1080/01459740.2014.892483.Google Scholar
- 55.Higgins JP. Nonlinear systems in medicine. Yale J Biol Med. 2001;75:247–60.Google Scholar
- 64.Rieck AM. Exploring the nature of power distance on general practitioner and community pharmacist relations in a chronic disease management context. J Interprof Care. 2014. doi:10.3109/13561820.2014.906390.Google Scholar
- 65.Liddy C, Mill K. An environmental scan of policies in support of chronic disease self-management in Canada. Chr Dis Inj Can. 2014;34:55–63.Google Scholar
- 67.Mackenzie L. Can chronic disease management plans including occupational therapy and physiotherapy services contribute to reducing falls risk in older people? Austr Fam Phys. 2014;43:211–5.Google Scholar
- 68.Brooks AT, Andrade RE, Middleton KR, et al. Social support: a key variable for health promotion and chronic disease management in Hispanic patients with rheumatic diseases. Clin Med Insights Arthr Musculoskel Dis. 2014;7:21–6.Google Scholar
- 69.Drutchas A, Anandarajah G. Spirituality and coping with chronic disease in pediatrics. Rhode Island Med J. 2014;97:26–30.Google Scholar
- 75.Wigg AJ, Chinnaratha MA, Wundke R, et al. A chronic disease management model for chronic liver failure. Hepatology. 2014. doi:10.1002/hep.27152.Google Scholar
- 78.Bain L, Kennedy C, Archibald D, et al. A training program designed to improve interprofessional knowledge, skills and attitudes in chronic disease settings. J Interprof Care. 2014. doi:10.3109/13561820.2014.898622.Google Scholar
- 80.Clarke JL. Preventive medicine: a ready solution for a health care system in crisis. Popul Health Manage. 2010;10:S3–11.Google Scholar